HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Daunorubicin, cytosine arabinoside and 6-thioguanine (DAT) combination chemotherapy for the treatment of acute non-lymphocytic leukemia.

AuthorsS Amadori, G Papa, G Meloni, L Pacilli, F Mandelli
JournalLeukemia research (Leuk Res) Vol. 3 Issue 3 Pg. 147-52 ( 1979) ISSN: 0145-2126 [Print] ENGLAND
PMID470431 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Cytarabine
  • Thioguanine
  • Daunorubicin
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents (administration & dosage)
  • Child
  • Child, Preschool
  • Cytarabine (administration & dosage, adverse effects)
  • Daunorubicin (administration & dosage, adverse effects)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Leukemia (drug therapy, mortality)
  • Male
  • Middle Aged
  • Thioguanine (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD